When "Good Enough" Is Good Enough For Finding Obviousness - Patent
In Cornell Research Foundation, Inc. v. Vidal, No. 2020-2334, 2022 WL 1634223 (Fed. Cir. May 24, 2022) (non-precedential), the Court of Appeals for the Federal Circuit affirmed the final written decision of the Patent Trial and Appeal Board's decision finding the challenged claims in six inter partes review proceedings unpatentable as anticipated or obvious.
United Kingdom Glaxo Inc British Foods Cornell Research Foundation Inc Novopharm Ltd Cornell Research Foundation
Source: mondaq.com